Skip to results
Modify your search
NARROW
1-20 of 28
Authors: Francesco Pignatti
Journal Article
The EMA Assessment of Asciminib for the Treatment of Adult Patients With Philadelphia Chromosome-Positive Chronic Myeloid Leukemia in Chronic Phase Who Were Previously Treated With at Least Two Tyrosine Kinase Inhibitors Open Access
The Oncologist, Volume 28, Issue 7, July 2023, Pages 628–632, https://doi.org/10.1093/oncolo/oyad119
Published: 04 May 2023
Journal Article
EMA Review of Isatuximab in Combination with Pomalidomide and Dexamethasone for the Treatment of Adult Patients with Relapsed and Refractory Multiple Myeloma Free
The Oncologist, Volume 26, Issue 11, November 2021, Pages 983–987, https://doi.org/10.1002/onco.13892
Published: 19 July 2021
Journal Article
EMA Review of Acalabrutinib for the Treatment of Adult Patients with Chronic Lymphocytic Leukemia Free
The Oncologist, Volume 26, Issue 3, March 2021, Pages 242–249, https://doi.org/10.1002/onco.13685
Published: 10 February 2021
Journal Article
EMA Review of Belantamab Mafodotin (Blenrep) for the Treatment of Adult Patients with Relapsed/Refractory Multiple Myeloma Free
The Oncologist, Volume 26, Issue 1, January 2021, Pages 70–76, https://doi.org/10.1002/onco.13592
Published: 23 November 2020
Journal Article
EMA Review of Daratumumab (Darzalex) for the Treatment of Adult Patients Newly Diagnosed with Multiple Myeloma Free
The Oncologist, Volume 25, Issue 12, December 2020, Pages 1067–1074, https://doi.org/10.1002/onco.13554
Published: 16 October 2020
Journal Article
EMA Review of Axicabtagene Ciloleucel (Yescarta) for the Treatment of Diffuse Large B‐Cell Lymphoma Free
The Oncologist, Volume 25, Issue 10, October 2020, Pages 894–902, https://doi.org/10.1634/theoncologist.2019-0646
Published: 27 April 2020
Journal Article
EMA Review of Daunorubicin and Cytarabine Encapsulated in Liposomes (Vyxeos, CPX‐351) for the Treatment of Adults with Newly Diagnosed, Therapy‐Related Acute Myeloid Leukemia or Acute Myeloid Leukemia with Myelodysplasia‐Related Changes Free
The Oncologist, Volume 25, Issue 9, September 2020, Pages e1414–e1420, https://doi.org/10.1634/theoncologist.2019-0785
Published: 13 April 2020
Journal Article
The European Medicines Agency Review of Gilteritinib (Xospata) for the Treatment of Adult Patients with Relapsed or Refractory Acute Myeloid Leukemia with an FLT3 Mutation Free
The Oncologist, Volume 25, Issue 7, July 2020, Pages e1070–e1076, https://doi.org/10.1634/theoncologist.2019-0976
Published: 10 March 2020
Journal Article
EMA Recommendation for the Pediatric Indications of Plerixafor (Mozobil) to Enhance Mobilization of Hematopoietic Stem Cells for Collection and Subsequent Autologous Transplantation in Children with Lymphoma or Malignant Solid Tumors Free
The Oncologist, Volume 25, Issue 6, June 2020, Pages e976–e981, https://doi.org/10.1634/theoncologist.2019-0898
Published: 10 March 2020
Journal Article
Blinatumomab for Acute Lymphoblastic Leukemia: The First Bispecific T‐Cell Engager Antibody to Be Approved by the EMA for Minimal Residual Disease Free
The Oncologist, Volume 25, Issue 4, April 2020, Pages e709–e715, https://doi.org/10.1634/theoncologist.2019-0559
Published: 14 November 2019
Journal Article
The European Medicines Agency Review of Kymriah (Tisagenlecleucel) for the Treatment of Acute Lymphoblastic Leukemia and Diffuse Large B‐Cell Lymphoma Free
The Oncologist, Volume 25, Issue 2, February 2020, Pages e321–e327, https://doi.org/10.1634/theoncologist.2019-0233
Published: 16 October 2019
Journal Article
The EMA Review of Mylotarg (Gemtuzumab Ozogamicin) for the Treatment of Acute Myeloid Leukemia Free
The Oncologist, Volume 24, Issue 5, May 2019, Pages e171–e179, https://doi.org/10.1634/theoncologist.2019-0025
Published: 21 March 2019
Journal Article
EMA Review of Panobinostat (Farydak) for the Treatment of Adult Patients with Relapsed and/or Refractory Multiple Myeloma Free
The Oncologist, Volume 23, Issue 7, July 2018, Page 870, https://doi.org/10.1634/theoncologist.2017-0301erratum
Published: 23 July 2018
Journal Article
EMA Review of Daratumumab for the Treatment of Adult Patients with Multiple Myeloma Free
The Oncologist, Volume 23, Issue 5, May 2018, Pages 594–602, https://doi.org/10.1634/theoncologist.2017-0328
Published: 25 January 2018
Journal Article
EMA Review of Panobinostat (Farydak) for the Treatment of Adult Patients with Relapsed and/or Refractory Multiple Myeloma Free
The Oncologist, Volume 23, Issue 5, May 2018, Pages 631–636, https://doi.org/10.1634/theoncologist.2017-0301
Published: 30 November 2017
Journal Article
Individual Trade‐Offs Between Possible Benefits and Risks of Cancer Treatments: Results from a Stated Preference Study with Patients with Multiple Myeloma Free
The Oncologist, Volume 23, Issue 1, January 2018, Pages 44–51, https://doi.org/10.1634/theoncologist.2017-0257
Published: 27 October 2017
Journal Article
The European Medicines Agency Review of Carfilzomib for the Treatment of Adult Patients with Multiple Myeloma Who Have Received at Least One Prior Therapy Free
The Oncologist, Volume 22, Issue 11, November 2017, Pages 1339–1346, https://doi.org/10.1634/theoncologist.2017-0184
Published: 21 September 2017
Journal Article
The European Medicines Agency Review of Decitabine (Dacogen) for the Treatment of Adult Patients With Acute Myeloid Leukemia: Summary of the Scientific Assessment of the Committee for Medicinal Products for Human Use Free
The Oncologist, Volume 21, Issue 6, June 2016, Pages 692–700, https://doi.org/10.1634/theoncologist.2015-0298
Published: 18 April 2016
Journal Article
The European Medicines Agency Review of Brentuximab Vedotin (Adcetris) for the Treatment of Adult Patients With Relapsed or Refractory CD30+ Hodgkin Lymphoma or Systemic Anaplastic Large Cell Lymphoma: Summary of the Scientific Assessment of the Committee for Medicinal Products for Human Use Free
The Oncologist, Volume 21, Issue 1, January 2016, Pages 102–109, https://doi.org/10.1634/theoncologist.2015-0276
Published: 30 November 2015
Journal Article
The European Medicines Agency Review of Pomalidomide in Combination With Low-Dose Dexamethasone for the Treatment of Adult Patients With Multiple Myeloma: Summary of the Scientific Assessment of the Committee for Medicinal Products for Human Use Free
The Oncologist, Volume 20, Issue 3, March 2015, Pages 329–334, https://doi.org/10.1634/theoncologist.2014-0073
Published: 11 February 2015
